Literature DB >> 34017078

ING2 tumor suppressive protein translocates into mitochondria and is involved in cellular metabolism homeostasis.

Charles Ricordel1,2, Laura Chaillot1, Alice Blondel1, Jérôme Archambeau1, Florence Jouan1, Audrey Mouche1, Marie Tiercin3, Agnès Burel4, Hervé Lena1,2, Benoît Desrues1,2, Thierry Guillaudeux1,4, Rémy Pedeux5.   

Abstract

ING2 (Inhibitor of Growth 2) is a tumor suppressor gene that has been implicated in critical biological functions (cell-cycle regulation, replicative senescence, DNA repair and DNA replication), most of which are recognized hallmarks of tumorigenesis occurring in the cell nucleus. As its close homolog ING1 has been recently observed in the mitochondrial compartment, we hypothesized that ING2 could also translocate into the mitochondria and be involved in new biological functions. In the present study, we demonstrate that ING2 is imported in the inner mitochondrial fraction in a redox-sensitive manner in human cells and that this mechanism is modulated by 14-3-3η protein expression. Remarkably, ING2 is necessary to maintain mitochondrial ultrastructure integrity without interfering with mitochondrial networks or polarization. We observed an interaction between ING2 and mtDNA under basal conditions. This interaction appears to be mediated by TFAM, a critical regulator of mtDNA integrity. The loss of mitochondrial ING2 does not impair mtDNA repair, replication or transcription but leads to a decrease in mitochondrial ROS production, suggesting a detrimental impact on OXPHOS activity. We finally show using multiple models that ING2 is involved in mitochondrial respiration and that its loss confers a protection against mitochondrial respiratory chain inhibition in vitro. Consequently, we propose a new tumor suppressor role for ING2 protein in the mitochondria as a metabolic shift gatekeeper during tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34017078     DOI: 10.1038/s41388-021-01832-3

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  49 in total

1.  The von Hippel-Lindau tumor suppressor targets to mitochondria.

Authors:  Y H Shiao; J H Resau; K Nagashima; L M Anderson; G Ramakrishna
Journal:  Cancer Res       Date:  2000-06-01       Impact factor: 12.701

Review 2.  Mitochondria and Cancer.

Authors:  Sejal Vyas; Elma Zaganjor; Marcia C Haigis
Journal:  Cell       Date:  2016-07-28       Impact factor: 41.582

3.  The antioxidant function of the p53 tumor suppressor.

Authors:  Anna A Sablina; Andrei V Budanov; Galina V Ilyinskaya; Larissa S Agapova; Julia E Kravchenko; Peter M Chumakov
Journal:  Nat Med       Date:  2005-11-13       Impact factor: 53.440

4.  ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation.

Authors:  Yannick Doyon; Christelle Cayrou; Mukta Ullah; Anne-Julie Landry; Valérie Côté; William Selleck; William S Lane; Song Tan; Xiang-Jiao Yang; Jacques Côté
Journal:  Mol Cell       Date:  2006-01-06       Impact factor: 17.970

5.  Nrf2 prevents initiation but accelerates progression through the Kras signaling pathway during lung carcinogenesis.

Authors:  Hironori Satoh; Takashi Moriguchi; Jun Takai; Masahito Ebina; Masayuki Yamamoto
Journal:  Cancer Res       Date:  2013-04-22       Impact factor: 12.701

6.  The retinoblastoma protein induces apoptosis directly at the mitochondria.

Authors:  Keren I Hilgendorf; Elizaveta S Leshchiner; Simona Nedelcu; Mindy A Maynard; Eliezer Calo; Alessandra Ianari; Loren D Walensky; Jacqueline A Lees
Journal:  Genes Dev       Date:  2013-04-25       Impact factor: 11.361

Review 7.  Mitochondria and cancer.

Authors:  Douglas C Wallace
Journal:  Nat Rev Cancer       Date:  2012-10       Impact factor: 60.716

8.  Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression.

Authors:  Carola A Neumann; Daniela S Krause; Christopher V Carman; Shampa Das; Devendra P Dubey; Jennifer L Abraham; Roderick T Bronson; Yuko Fujiwara; Stuart H Orkin; Richard A Van Etten
Journal:  Nature       Date:  2003-07-31       Impact factor: 49.962

Review 9.  Mitochondria and Cancer.

Authors:  Wei-Xing Zong; Joshua D Rabinowitz; Eileen White
Journal:  Mol Cell       Date:  2016-03-03       Impact factor: 17.970

Review 10.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

View more
  1 in total

Review 1.  Inhibitor of Growth Factors Regulate Cellular Senescence.

Authors:  Soudeh Ghafouri-Fard; Mohammad Taheri; Aria Baniahmad
Journal:  Cancers (Basel)       Date:  2022-06-24       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.